Craft

Tropic Biosciences

Total Funding

$38.5 M

Revenue

£730.1 K

FY, 2023

Tropic Biosciences Summary

Company Summary

Overview
Tropic Biosciences is a biotechnology company that uses advanced plant breeding and gene editing technologies to develop commercial tropical crops such as coffee, rice, and bananas. It delivers gene editing with gene silencing technology that allows to make changes to crop genomes to activate natural disease resistance.
Type
Private
Status
Active
Founded
2016
HQ
Norfolk, GB | view all locations
Website
https://tropic.bio/
Cybersecurity rating
Sectors

Key People

  • Eyal Maori

    Eyal Maori, Co-Founder, Chief Science Officer

  • Jean-Marie Graux

    Jean-Marie Graux, Chief Marketing Officer (CMO)

  • Gilad Gershon

LocationsView all

1 location detected

  • Norfolk, England HQ

    United Kingdom

    Norwich Research Park Innovation Centre, NR4 7GJ

Tropic Biosciences Financials

Summary Financials

Revenue (FY, 2023)
£730.1K
Gross profit (FY, 2023)
£305.6K
Net income (FY, 2023)
(£14.8M)
Cash (FY, 2023)
£17.3M
EBIT (FY, 2023)
(£13.4M)

Footer menu